Genetically engineered immune privileged Sertoli cells: A new road to cell based gene therapy. Academic Article

abstract

• Sertoli cells are immune privileged cells, important for controlling the immune response to male germ cells as well as maintaining the tolerogenic environment in the testis. Additionally, ectopic Sertoli cells have been shown to survive and protect co-grafted cells when transplanted across immunological barriers. The survival of ectopic Sertoli cells has led to the idea that they could be used in cell based gene therapy. In this review, we provide a brief overview of testis immune privilege and Sertoli cell transplantation, factors contributing to Sertoli cell immune privilege, the challenges faced by viral vector gene therapy, the use of immune privileged cells in cell based gene therapy and describe several recent studies on the use of genetically engineered Sertoli cells to provide continuous delivery of therapeutic proteins.

authors

• Long, Charles

published proceedings

• Spermatogenesis

author list (cited authors)

• Kaur, G., Long, C. R., & Dufour, J. M.

citation count

• 23

complete list of authors

• Kaur, Gurvinder||Long, Charles R||Dufour, Jannette M

publication date

• January 2012

publisher

• Taylor & Francis  Publisher

published in

• Spermatogenesis  Journal

keywords

• 5 Development Of Treatments And Therapeutic Interventions
• 5.2 Cellular And Gene Therapies
• Biotechnology
• Contraception/reproduction
• Gene Therapy
• Genetics
• Transplantation

Digital Object Identifier (DOI)

• 10.4161/spmg.19119

start page

• 23

end page

• 31

volume

• 2

issue

• 1

URL

• http://dx.doi.org/10.4161/spmg.19119